Drug intelligence / Profile preview

calcipotriol + betamethasone

Development stage
Approved
Lead developer
LEO Pharma
Modality
Small Molecules
Administration
Topical
01

Overview

Calcipotriol + betamethasone is a fixed-dose topical combination of a synthetic vitamin D analogue (calcipotriol, also known as calcipotriene) and a potent synthetic corticosteroid (betamethasone dipropionate). It is primarily used for the treatment of plaque psoriasis on the skin and scalp in adults and adolescents. Calcipotriol acts by binding to the vitamin D receptor, regulating skin cell production and differentiation, thereby reducing excessive proliferation seen in psoriasis. Betamethasone exerts anti-inflammatory, immunosuppressive, antipruritic, and vasoconstrictive effects by activating glucocorticoid receptors. The combination provides superior efficacy compared to either agent alone by targeting both inflammation (betamethasone) and abnormal keratinocyte proliferation/differentiation (calcipotriol). The product is available as ointment, gel, foam, cream or suspension formulations[1][2][4][5][6].

Brand names
EnstilarTaclonexTaclonex ScalpWynzoraDaivobetDovobetXamiol
Other names
calcipotriene + betamethasone dipropionate
02

Targets

GR (Glucocorticoid receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on calcipotriol + betamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on calcipotriol + betamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call